EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,700 Cr | ₹1,888 Cr | ₹1,044 Cr | ₹817 Cr | ₹459 Cr |
What is the latest Net Current Assets ratio of EMCURE PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹1,700 Cr |
| Mar2025 | ₹1,888 Cr |
| Mar2024 | ₹1,044 Cr |
| Mar2023 | ₹817 Cr |
| Mar2022 | ₹459 Cr |
How is Net Current Assets of EMCURE PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,700 Cr | -9.95 | |
| Mar2025 | ₹1,888 Cr | 80.80 | |
| Mar2024 | ₹1,044 Cr | 27.83 | |
| Mar2023 | ₹817 Cr | 77.83 | |
| Mar2022 | ₹459 Cr | - | |
Compare Net Current Assets of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹44,370.8 Cr | 4.6% | 28.3% | 74.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,852.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| CIPLA | ₹111,731.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 4.6% |
28.3% |
74.7% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses